Startups · Gothenburg, Sweden

MucoLife Therapeutics

an inhaled drug that dissolves mucus plugs in the lungs

Website · Sector: Health

Svenska

From our lists 10 new startups in Gothenburg worth knowing (2026) and 39 new startups in Sweden worth knowing (2026)

MucoLife Therapeutics develops MLT-001, an experimental inhaled peptide meant to dissolve the mucus plugs that block the airways in COPD; according to Tech.eu, such plugs occur in more than half of patients with moderate-to-severe COPD and no approved therapy targets them directly. Founded in 2024 by CEO Thaher Pelaseyed and Gunnar C. Hansson as a spin-out of the mucin biology research groups at the University of Gothenburg, it received 1 million kronor (91,000 euro) from Sweden's innovation agency Vinnova to set up a scalable manufacturing process for MLT-001, as Tech.eu reported on 6 November 2026. Website: mucolife.com. Source: Tech.eu, Tech.eu interview.

Questions about MucoLife Therapeutics

What does MucoLife Therapeutics do?

MucoLife Therapeutics: an inhaled drug that dissolves mucus plugs in the lungs.

Where is MucoLife Therapeutics based?

MucoLife Therapeutics is based in Gothenburg, Sweden.

Where can I read more about MucoLife Therapeutics?

MucoLife Therapeutics is in our list 10 new startups in Gothenburg worth knowing (2026): https://meetnewbrands.com/articles/new-startups-in-gothenburg-2026

All Swedish startups

Is this your startup?Get a free founder story written with you, or add your latest funding round. Something out of date? Tell us.Pitch your story